Related Experiment Video
Updated: Jun 6, 2025

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Ixekizumab: an alternative for HIV-positive psoriasis patients
Fanghua Liu1, Zhou Liu1, Rongming Yang1
1Department of Dermatology, Ganzhou Municipal Hospital, Ganzhou, Jiangxi Province, 341000, People's Republic of China.
Abstract:
Psoriasis is a recurrent and protracted inflammatory disease. Generalized erythema, plaques, and silvery scales on the surface mainly characterize its skin lesions. Biologics bring new hope to psoriasis patients. However, HIV infection is a major concern before receiving biologics. Here, we present a case of the efficacy and safety of Ixekizumab, an interleukin 17 inhibitor, in the treatment of psoriasis patients living with HIV (PPLHIV).
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Retrovirus Life Cycles

